CASP3 and type 2 diabetes mellitus: The treatment of FXC+UCMSCs was able to attenuate the aortic injury of T2DM, and significantly inhibited the blood glucose, TG, TC, LDL-C, cleaved caspase-3, and Bax levels in rats.